[OFER] NAC: Job offer Director of Virology

***********************************************************************
(c)OFER-TRABEC OFER-TRABEC OFER-TRABEC OFER-TRABEC OFER-TRABEC
(http://www.rediris.es/list/sdis/ofer-trabec/) es una gentileza de:
Centro de Información Administrativa de Presidencia del Gobierno
Centro de Comunicaciones RedIRIS (http://www.rediris.es)
(Permitida la reproducción siempre que se cite la fuente de este Servicio).
***********************************************************************
Becas, ayudas y subvenciones
http://www.060.es/te_ayudamos_a/ayudas_becas_y_subvenciones/common/becas.pdf
***********************************************************************
Servicios de Distribución de RedIRIS: http://www.rediris.es/list/sdis/
*************************************************************************
Para darse de baja OFER-TRABEC pinche y envie:
mailto:OFER-TRABEC-signoff-request@listserv.rediris.es
*************************************************************************

---Procedencia:
Institución:Innovative Bioconsulting
Contacto correo-e:consultoria@innobc.com
---
Ref. 0201

Our customer is looking for a DIRECTOR OF VIROLOGY to lead R&D activities on this area. She/he will lead a team of 10 people (4 PhD scientists and 6 engineers). The team is likely to grow to cover our customer needs. The chosen person will work very close to Nantes, France.
The Person
The person must now viruses as Biology and be familiar about:
• virus replication
• virus interaction
• virus purification
• virus cell interaction

She / he should have:

• A PhD in a life science subject
• 5 to 10 years experience preferably working with viruses
• Ideally, experience of a small company to understand the limitations this brings on both resources and expenses
• Ideally previous experience of leading small interactive teams

Also if the person has had previous experience with external clients/projects this would be an advantage
The personal qualities of the individual will be as important as his/her qualifications and experience. These should include:
• The positive and enthusiastic personality required of a successful leader and the energy, drive and stamina to bring projects to a successful conclusion;
• A "hands-on", adaptable and flexible approach, comfortable working in a small team, but with the ability to grow and develop as the needs of the company change;
• Result orientated, but with the ability to set realistic targets for both his/her own team and others;
• Fluency in English, both written and oral are essential, additional languages, especially French are highly desirable.

REWARDS
• A direct and personal impact on the future shape and success of the Company;
• A competitive salary
• Bonus scheme for achievement of goals.
• Relocation support and French language course, if needed

OUR CUSTOMER
The company spent the next few years developing a recognized scientific and technical expertise in avian ES cells, with the aim to apply these technologies to genetically improve avian species of commercial interest.
The work on ES cells did not provide the potential originally envisaged for avian transgenesis but it was identified that avian ES cells held a tremendous potential for the commercial production of human and veterinary viral vaccines. In 2003, the team focused on these industrial applications and obtained the first commercial licenses
These achievements drove the development of the commercial value of the company and the company was able to successfully carry out an IPO in 2007 which was 7 times over subscribed. The company is in a very strong position since with current commercial licenses in place and the funds raised via the IPO, the company has in excess of 4 years cash. By focussing on proprietary processes and technology platforms, they could develop a strong business model of Up-Front and Milestone payments, coupled to a significant license royalty fee. The current business plan of the company is to further develop the vaccine and protein manufacturing sector, but also based on research and development already performed, to move into the co-development and development of proprietary products for the vaccine and therapeutic protein areas. The company is already actively involved in the co-development of an anti-cancer monoclonal antibody and a recombinant vaccine against an infectious disease, and i!
ts development team is currently being further expanded. Major additional deals with leaders in the vaccine industry have now been signed with licensees such as GSK, CSL, Kaketsuken and Intervet.

----------------
Información complementaria de la oferta:
IF YOU ARE INTERESTED IN THIS JOB OFFER, PLEASE SEND US YOUR CV TO consultoria@innobc.com If not, please, feel free to share it with your contacts.

----------------------------------------------------
Los artículos de OFER-TRABEC son distribuidos gracias al apoyo y colaboración
técnica de RedIRIS - Red Académica española - (http://www.rediris.es)
----------------------------------------------------